Since the first “test-tube baby” was born in 1978, in-vitro fertilization (IVF) has been an astonishing game changer when it comes to helping people to conceive. However, as amazing as it is, its success rate still typically hovers around 30 percent. That means that seven out of ten attempts will fail. This can be extremely taxing to would-be parents not only financially, but also mentally and physically. Could A.I. help improve those odds and, in the process, play an important role in the birth of many of tomorrow’s babies?
According to investigators from Brigham and Women’s Hospital and Massachusetts General Hospital, the answer looks to be a resounding “yes.” They are working on a deep-learning A.I. that can help decide on which embryos should be transferred during an IVF round.
“The IVF process involves the insemination of eggs and the culture of embryos externally in a fertility lab before transferring the developed embryo to the mother,” Hadi Shafiee, one of the lead researchers from the Division of Engineering in Medicine at Brigham and Women’s Hospital, told Digital Trends. “A major challenge in the field is deciding on the embryos that need to be transferred during IVF, such that chances of a healthy birth are maximal and any complications for both mother and child are minimal. Currently, the tools available to embryologists when making such are extremely limited and expensive, and, thus, most embryologists are required to make these life-altering decisions using only their observational skills and expertise. In such scenarios, their decision-making process is extremely subjective and tends to be variable.”
An A.I. system used to analyze 742 embryos proved to be 90% accurate at the job of selecting the most high-quality embryo. It does this by evaluating images taken with the microscopes used at fertility centers. While the researchers make clear that this would not be a replacement for human experts, it could help inform decisions that usually have to be assessed manually. (It’s also important to note that IVF doesn’t only fail because of an improperly selected, non-optimal embryo, although this is understood to be a contributing factor.)
As for the next step, Shafiee noted that, “The most important hurdle for such [a] system to be used in clinic is conducting a prospective randomized clinical trial for system validation to pass regulatory requirements.”
A paper describing the work was recently published in the journal eLife.
Recently, we've entered an exciting collaboration with Maple Media, creating a bundle of 17 apps worth having on your phone. From relaxed fun to serious productivity boosts, these apps cover all your bases and provide a fun boost to your phone. Normally, the bundle is $9.99 per month (far lower than the cost of using the apps individually), but for your first 7 days you can get access to the bundle for free. View the full Digital Trends App Bundle for a complete list of the apps, or read on for a summarized take.
What's happened? This week, China's Quality Certification Center released information about a battery (EB-BS04898ABY) with a maximum capacity of 4,855mAh. That's the same capacity as was previously seen in the Samsung Galaxy S25 Ultra, and fans have taken this certification to mean the Galaxy S26 Ultra will not see a capacity increase after all.
The Samsung Galaxy Ultra models have had the same battery capacity for the last five years.
What's happened? Samsung has officially announced the Galaxy Tab S10 Lite, a budget-friendly alternative to the Galaxy Tab S10. The device has been rumored for months, but this is the first time Samsung has officially acknowledged its existence.
The Galaxy Tab S10 Lite will have a 10.9-inch display and a peak brightness of 600 nits — a bit on the lower side, versus the iPad Pro's maximum brightness of 1,600 nits.